Ms Stephanie A. Capistron > Dechert LLP > Boston, United States > Lawyer Profile
Dechert LLP Offices
ONE INTERNATIONAL PLACE
40TH FLOOR, 100 OLIVER STREET
BOSTON, MA 02110-2605
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Ms Stephanie A. Capistron
Work Department
Financial Services and Investment Management
Career
Stephanie A. Capistron advises U.S. registered investment companies and their investment advisers on a wide variety of regulatory, compliance and corporate matters, including the development and launch of new funds, regulatory and compliance matters relating to existing funds, fund reorganizations and requests for exemptive relief from the Securities and Exchange Commission. Ms. Capistron also regularly provides advice on affiliated transaction matters under the Investment Company Act of 1940.
Ms. Capistron has significant experience assisting mutual fund sponsors launch exchange-traded fund business lines, including advice with respect to fund structure, disclosure and listing requirements, and development of compliance programs for exchange-traded funds.
She also advises boards of directors/trustees of U.S. registered investment companies on fund governance and fiduciary oversight matters, including director/trustee independence and regulatory examinations.
Education
- Providence College, B.A., 2005, summa cum laude
- Boston College Law School, J.D., 2008, magna cum laude
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation